Metropolitan Life Insurance Company (MetLife)’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,585	Closed	-$92.1K	–	2754
2021 Q4	$92.1K	Hold	6,585	–	–	﹤0.01%	2530
2021 Q3	$170K	Hold	6,585	–	–	﹤0.01%	2194
2021 Q2	$301K	Buy	6,585 +320	+5%	+$15.1K	﹤0.01%	1857
2021 Q1	$276K	Buy	6,265 +2,411	+63%	+$117K	﹤0.01%	1796
2020 Q4	$119K	Hold	3,854	–	–	﹤0.01%	2268
2020 Q3	$123K	Buy	+3,854	New	+$94.6K	﹤0.01%	2096

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AMTI Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2022, closing a stake of 6,585 shares — an estimated $92.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMTI in Q3 2020 and held it in 6 quarters. The position peaked at $301K in Q2 2021. 77 funds tracked by Wall St. Rank hold AMTI as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,585 Applied Molecular Transport Inc. Common Stock shares in Q1 2022, an estimated $92.1K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Metropolitan Life Insurance Company (MetLife)'s Applied Molecular Transport Inc. Common Stock position peaked at $301K in Q2 2021.
77 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.